is metformin a glp-1 drug New aspects of an old drug: as glucagon-like peptide 1 (GLP-1) enhancer and sensitiser | Diabetologia Metformin vs GLP-1: Key Differences

Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis

After approval, Novo Nordisk is required to conduct a pediatric trial in adolescents younger than 18 years of age and to add semaglutide to a 15-year medullary thyroid carcinoma registry that includes all of the long-acting GLP-1 products

They are made by different companies (Innovent Biologics and Eli Lilly, respectively), have different clinical trial programs, and produce different levels of weight loss

Scientific report of the 2025 dietary guidelines advisory committee: advisory report to the secretary of health and human services and secretary of agriculture

More recent research continues to suggest that there may be a signal worth paying attention to